[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627915":3},{"organization":4,"outcomesModule":7,"designInfo":65,"detailedDescription":71,"studyPopulation":29,"armGroups":72,"interventions":84,"overallOfficials":29,"centralContacts":98,"locations":107,"responsibleParty":474,"collaborators":29,"id":476,"slug":477,"hasResults":478,"nctId":479,"briefTitle":480,"officialTitle":481,"acronym":29,"eligibilityCriteria":482,"healthyVolunteers":478,"sex":483,"minAge":484,"maxAge":29,"enrollmentInfo":485,"targetDuration":29,"studyType":488,"phases":489,"briefSummary":492,"conditions":493,"keywords":29,"overallStatus":110,"whyStopped":29,"lastUpdateSubmitDate":495,"lastUpdatePostDateStruct":496,"startDateStruct":499,"completionDateStruct":501,"leadSponsor":503,"locationsCount":504},{"fullName":5,"class":6},"Mirum Pharmaceuticals, Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":29},[9],{"measure":10,"description":11,"timeFrame":12},"Proportion of participants with undetectable HDV RNA (\u003CLLOQ Target not detected [TND])","The proportion of participants with undetectable HDV RNA (\\\u003CLLOQ, TND) at Week 24","Week 24",[14,18,21,24,27,30,32,34,37,39,41,44,47,50,53,56,59,62],{"measure":15,"description":16,"timeFrame":17},"Incidence and severity of treatment-emergent adverse events (TEAEs)","Incidence and severity of treatment-emergent adverse events (TEAEs) during brelovitug and bulevirtide treatment periods.","Up to Week 96",{"measure":19,"description":20,"timeFrame":17},"Proportion of participants who permanently discontinue treatment due to an adverse event","Proportion of participants who permanently discontinue study treatment because of an adverse event.",{"measure":22,"description":23,"timeFrame":17},"Change from baseline in serum total bile salts","Mean change from baseline in serum total bile salt levels.",{"measure":25,"description":26,"timeFrame":17},"Proportion of participants achieving virologic response (HDV RNA ≥2 log10 IU\u002FmL decline from baseline or HDV RNA \u003CLLOQ, TND)","Proportion of participants with virologic response at Weeks 24, 48, 72, and 96.",{"measure":28,"description":29,"timeFrame":17},"Proportion of participants achieving HDV RNA \u003C LLOQ at Weeks 24, 48, 72 and 96.",null,{"measure":31,"description":29,"timeFrame":17},"Proportion of participants achieving HDV RNA (HDV RNA \u003C LLOQ, TND) at Weeks 48, 72, and 96.",{"measure":33,"description":29,"timeFrame":17},"Proportion of participants achieving normal ALT at Weeks 24, 48, 72 and 96.",{"measure":35,"description":36,"timeFrame":17},"Proportion of participants achieving normal ALT with virologic response (HDV RNA ≥2 log10 IU\u002FmL decline from baseline or HDV RNA \u003CLLOQ, TND)","Proportion of participants with normal ALT and virologic response at Weeks 24, 48, 72, and 96.",{"measure":38,"description":29,"timeFrame":17},"Proportion of participants achieving normal ALT with HDV RDA \u003C LLOQ at Weeks 24, 48, 72 and 96.",{"measure":40,"description":29,"timeFrame":17},"Proportion of participants achieving normal ALT with HDV RNA (HDV RNA \u003C LLOQ, TND) at Weeks 24, 48, 72 and 96",{"measure":42,"description":43,"timeFrame":17},"Change from baseline in HDV RNA","Change from baseline in HDV RNA levels over time during treatment.",{"measure":45,"description":46,"timeFrame":17},"Change from baseline in ALT levels","Change from baseline ALT levels over time during treatment.",{"measure":48,"description":49,"timeFrame":17},"Change from baseline in liver stiffness","Change from baseline in liver stiffness as determined by transient elastography at weeks 24, 48 and 96",{"measure":51,"description":52,"timeFrame":17},"Change from baseline in APRI","Change from baseline in APRI at weeks 24, 48, and 96",{"measure":54,"description":55,"timeFrame":17},"Change in baseline in CTP score","Change from baseline in CTP score at Weeks 24, 48, and 96 in participants with cirrhosis",{"measure":57,"description":58,"timeFrame":17},"Change from baseline in MELD score","Change from baseline in MELD score at Weeks 24, 48, and 96 in participants with cirrhosis",{"measure":60,"description":61,"timeFrame":17},"Proportion of participants with clinical disease progression from baseline","Proportion of participants with clinical disease progression from baseline in HDV-associated liver disease at Weeks 24, 48, and 96.",{"measure":63,"description":29,"timeFrame":64},"Proportion of participants who achieve HDV RNA \u003C LLOQ, TND at post-treatment follow-up","Up to Week 48",{"allocation":66,"interventionModel":67,"interventionModelDescription":29,"primaryPurpose":68,"observationalModel":29,"timePerspective":29,"maskingInfo":69},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":70,"maskingDescription":29,"whoMasked":29},"NONE","This is a Phase 2b\u002F3, open-label, multicenter study evaluating the efficacy and safety of switching participants on bulevirtide to brelovitug for the treatment of chronic hepatitis delta (CHD).",[73,79],{"label":74,"type":75,"description":76,"interventionNames":77},"Immediate Switch to Brelovitug","EXPERIMENTAL","Participants will switch to brelovitug 300 mg once weekly for 96 weeks.",[78],"Drug: Brelovitug (BJT-778)",{"label":80,"type":75,"description":81,"interventionNames":82},"Delayed Switch from Bulevirtide to Brelovitug","Participants will continue bulevirtide once daily and then switch to brelovitug 300 mg once weekly for 72 weeks.",[83],"Drug: Bulevirtide",[85,92],{"type":86,"name":87,"description":88,"armGroupLabels":89,"otherNames":90},"DRUG","Brelovitug (BJT-778)","Brelovitug (BJT-778), 300 mg administered subcutaneously once weekly for 96 weeks.",[74],[91],"BJT-778",{"type":86,"name":93,"description":94,"armGroupLabels":95,"otherNames":96},"Bulevirtide","Bulevirtide - once daily. Brelovitug (BJT-778) - 300 mg once weekly for 72 weeks following bulevirtide.",[80],[91,97],"Hepcludex",[99,104],{"name":100,"role":101,"phone":102,"phoneExt":29,"email":103},"Clinical Trials Mirum","CONTACT","+16506674085","clinicaltrials@mirumpharma.com",{"name":105,"role":101,"phone":29,"phoneExt":29,"email":106},"Medinfo Mirum","medinfo@mirumpharma.com",[108,121,130,139,148,158,167,173,184,193,202,211,220,229,238,247,256,265,274,283,294,303,312,321,330,341,350,362,371,377,383,388,397,408,414,423,435,444,453,459,465],{"facility":109,"status":110,"city":111,"state":29,"zip":112,"country":113,"countryCode":114,"cosmosGeoPoint":115,"geoPoint":120,"contacts":29},"Medical University of Graz","RECRUITING","Graz","8010","Austria","AT",{"type":116,"coordinates":117},"Point",[118,119],15.44197,47.06733,{"lat":119,"lon":118},{"facility":122,"status":110,"city":123,"state":29,"zip":124,"country":113,"countryCode":114,"cosmosGeoPoint":125,"geoPoint":129,"contacts":29},"Medizinische Universitat Innsbruck","Innsbruck","A-6020",{"type":116,"coordinates":126},[127,128],11.39454,47.26266,{"lat":128,"lon":127},{"facility":131,"status":110,"city":132,"state":29,"zip":133,"country":113,"countryCode":114,"cosmosGeoPoint":134,"geoPoint":138,"contacts":29},"University Hospital St. Polten- Lilenfeld","Lilienfeld","3100",{"type":116,"coordinates":135},[136,137],15.59664,48.01312,{"lat":137,"lon":136},{"facility":140,"status":110,"city":141,"state":29,"zip":142,"country":113,"countryCode":114,"cosmosGeoPoint":143,"geoPoint":147,"contacts":29},"Medical University of Vienna","Vienna","1090",{"type":116,"coordinates":144},[145,146],16.37208,48.20849,{"lat":146,"lon":145},{"facility":149,"status":110,"city":150,"state":29,"zip":151,"country":152,"countryCode":29,"cosmosGeoPoint":153,"geoPoint":157,"contacts":29},"Fakultni Nemocnice Brno (University Hospital Brno)","Brno","62500","Czechia",{"type":116,"coordinates":154},[155,156],16.60796,49.19522,{"lat":156,"lon":155},{"facility":159,"status":110,"city":160,"state":29,"zip":161,"country":152,"countryCode":29,"cosmosGeoPoint":162,"geoPoint":166,"contacts":29},"Klin Med Ltd. (KLIN MED s.r.o.)","Prague","12000",{"type":116,"coordinates":163},[164,165],14.42076,50.08804,{"lat":165,"lon":164},{"facility":168,"status":110,"city":160,"state":29,"zip":169,"country":152,"countryCode":29,"cosmosGeoPoint":170,"geoPoint":172,"contacts":29},"Institut klinicke a experimentalni mediciny- IKEM (Institute for Clinical and Experimental Medicine)","14021",{"type":116,"coordinates":171},[164,165],{"lat":165,"lon":164},{"facility":174,"status":110,"city":175,"state":29,"zip":176,"country":177,"countryCode":178,"cosmosGeoPoint":179,"geoPoint":183,"contacts":29},"CHU de Bordeaux","Bordeaux","33076","France","FR",{"type":116,"coordinates":180},[181,182],-0.58046,44.84124,{"lat":182,"lon":181},{"facility":185,"status":110,"city":186,"state":29,"zip":187,"country":177,"countryCode":178,"cosmosGeoPoint":188,"geoPoint":192,"contacts":29},"Clermont-Ferrand University Hospital","Clermont-Ferrand","63100",{"type":116,"coordinates":189},[190,191],3.08682,45.77969,{"lat":191,"lon":190},{"facility":194,"status":110,"city":195,"state":29,"zip":196,"country":177,"countryCode":178,"cosmosGeoPoint":197,"geoPoint":201,"contacts":29},"Hospital Beaujon","Clichy","92110",{"type":116,"coordinates":198},[199,200],2.30952,48.90018,{"lat":200,"lon":199},{"facility":203,"status":110,"city":204,"state":29,"zip":205,"country":177,"countryCode":178,"cosmosGeoPoint":206,"geoPoint":210,"contacts":29},"Henri Mondor University Hospital (APHP)","Créteil","94000",{"type":116,"coordinates":207},[208,209],2.46569,48.79266,{"lat":209,"lon":208},{"facility":212,"status":110,"city":213,"state":29,"zip":214,"country":177,"countryCode":178,"cosmosGeoPoint":215,"geoPoint":219,"contacts":29},"CHU Grenoble Alpes Hopital Nord Michallon","Grenoble","38700",{"type":116,"coordinates":216},[217,218],5.71479,45.17869,{"lat":218,"lon":217},{"facility":221,"status":110,"city":222,"state":29,"zip":223,"country":177,"countryCode":178,"cosmosGeoPoint":224,"geoPoint":228,"contacts":29},"CHU Limoges","Limoges","87000",{"type":116,"coordinates":225},[226,227],1.24759,45.83362,{"lat":227,"lon":226},{"facility":230,"status":110,"city":231,"state":29,"zip":232,"country":177,"countryCode":178,"cosmosGeoPoint":233,"geoPoint":237,"contacts":29},"Hospital De La Croix Rousse","Lyon","69004",{"type":116,"coordinates":234},[235,236],4.84789,45.74906,{"lat":236,"lon":235},{"facility":239,"status":110,"city":240,"state":29,"zip":241,"country":177,"countryCode":178,"cosmosGeoPoint":242,"geoPoint":246,"contacts":29},"Hopital Saint-Eloi","Montpellier","34090",{"type":116,"coordinates":243},[244,245],3.87635,43.61093,{"lat":245,"lon":244},{"facility":248,"status":110,"city":249,"state":29,"zip":250,"country":177,"countryCode":178,"cosmosGeoPoint":251,"geoPoint":255,"contacts":29},"Pitie-Salpetriere Hosptial","Paris","75013",{"type":116,"coordinates":252},[253,254],2.3488,48.85341,{"lat":254,"lon":253},{"facility":257,"status":110,"city":258,"state":29,"zip":259,"country":177,"countryCode":178,"cosmosGeoPoint":260,"geoPoint":264,"contacts":29},"Chu de Rennes Hopital Pontchaillou","Rennes","35000",{"type":116,"coordinates":261},[262,263],-1.67431,48.11109,{"lat":263,"lon":262},{"facility":266,"status":110,"city":267,"state":29,"zip":268,"country":177,"countryCode":178,"cosmosGeoPoint":269,"geoPoint":273,"contacts":29},"CHU Toulouse Hospital Rangueil, Toulouse","Toulouse","31400",{"type":116,"coordinates":270},[271,272],1.44367,43.60426,{"lat":272,"lon":271},{"facility":275,"status":110,"city":276,"state":29,"zip":277,"country":177,"countryCode":178,"cosmosGeoPoint":278,"geoPoint":282,"contacts":29},"Centre Hospitalier de Versailles","Versailles","78150",{"type":116,"coordinates":279},[280,281],2.13424,48.80359,{"lat":281,"lon":280},{"facility":284,"status":110,"city":285,"state":29,"zip":286,"country":287,"countryCode":288,"cosmosGeoPoint":289,"geoPoint":293,"contacts":29},"University Hospital of Dusseldorf","Düsseldorf","40225","Germany","DE",{"type":116,"coordinates":290},[291,292],6.77927,51.22319,{"lat":292,"lon":291},{"facility":295,"status":110,"city":296,"state":29,"zip":297,"country":287,"countryCode":288,"cosmosGeoPoint":298,"geoPoint":302,"contacts":29},"Goethe University Frankfurt","Frankfurt","60323",{"type":116,"coordinates":299},[300,301],10.53333,49.68333,{"lat":301,"lon":300},{"facility":304,"status":110,"city":305,"state":29,"zip":306,"country":287,"countryCode":288,"cosmosGeoPoint":307,"geoPoint":311,"contacts":29},"ICH Study Center GmbH & Co KG","Hamburg","20146",{"type":116,"coordinates":308},[309,310],9.99302,53.55073,{"lat":310,"lon":309},{"facility":313,"status":110,"city":314,"state":29,"zip":315,"country":287,"countryCode":288,"cosmosGeoPoint":316,"geoPoint":320,"contacts":29},"Medizinische Hochschule Hannover","Hanover","30625",{"type":116,"coordinates":317},[318,319],9.73322,52.37052,{"lat":319,"lon":318},{"facility":322,"status":110,"city":323,"state":29,"zip":324,"country":287,"countryCode":288,"cosmosGeoPoint":325,"geoPoint":329,"contacts":29},"Universitatsmedizin Rostock","Rostock","18057",{"type":116,"coordinates":326},[327,328],12.14049,54.0887,{"lat":328,"lon":327},{"facility":331,"status":110,"city":332,"state":29,"zip":333,"country":334,"countryCode":335,"cosmosGeoPoint":336,"geoPoint":340,"contacts":29},"Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII","Bergamo","24127","Italy","IT",{"type":116,"coordinates":337},[338,339],9.66721,45.69601,{"lat":339,"lon":338},{"facility":342,"status":110,"city":343,"state":29,"zip":344,"country":334,"countryCode":335,"cosmosGeoPoint":345,"geoPoint":349,"contacts":29},"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","Milan","20122",{"type":116,"coordinates":346},[347,348],9.18951,45.46427,{"lat":348,"lon":347},{"facility":351,"status":110,"city":352,"state":353,"zip":354,"country":355,"countryCode":356,"cosmosGeoPoint":357,"geoPoint":361,"contacts":29},"Centrul Medical Unirea S.R.L","Iași","Lasi","700023","Romania","RO",{"type":116,"coordinates":358},[359,360],27.6,47.16667,{"lat":360,"lon":359},{"facility":363,"status":110,"city":364,"state":29,"zip":365,"country":355,"countryCode":356,"cosmosGeoPoint":366,"geoPoint":370,"contacts":29},"National Institute Of Infectious Diseases Prof. Dr. Matei Bals","Bucharest","021105",{"type":116,"coordinates":367},[368,369],26.10626,44.43225,{"lat":369,"lon":368},{"facility":372,"status":110,"city":364,"state":29,"zip":373,"country":355,"countryCode":356,"cosmosGeoPoint":374,"geoPoint":376,"contacts":29},"Fundeni Clinical Institute","022328",{"type":116,"coordinates":375},[368,369],{"lat":369,"lon":368},{"facility":378,"status":110,"city":364,"state":29,"zip":379,"country":355,"countryCode":356,"cosmosGeoPoint":380,"geoPoint":382,"contacts":29},"Clinical Hospital for Infectious and Tropical Diseases Dr. Victor Babes","030303",{"type":116,"coordinates":381},[368,369],{"lat":369,"lon":368},{"facility":363,"status":110,"city":364,"state":29,"zip":384,"country":355,"countryCode":356,"cosmosGeoPoint":385,"geoPoint":387,"contacts":29},"21105",{"type":116,"coordinates":386},[368,369],{"lat":369,"lon":368},{"facility":389,"status":110,"city":390,"state":29,"zip":391,"country":355,"countryCode":356,"cosmosGeoPoint":392,"geoPoint":396,"contacts":29},"Spitalul Clinic de Boli Infectioase Constanta","Constanța","900709",{"type":116,"coordinates":393},[394,395],28.63432,44.18073,{"lat":395,"lon":394},{"facility":398,"status":110,"city":399,"state":29,"zip":400,"country":401,"countryCode":402,"cosmosGeoPoint":403,"geoPoint":407,"contacts":29},"Vall d'Hebron Hospital","Barcelona","08035","Spain","ES",{"type":116,"coordinates":404},[405,406],2.15899,41.38879,{"lat":406,"lon":405},{"facility":409,"status":110,"city":399,"state":29,"zip":410,"country":401,"countryCode":402,"cosmosGeoPoint":411,"geoPoint":413,"contacts":29},"Hospital Clinic I Provincial De Barcelona","08036",{"type":116,"coordinates":412},[405,406],{"lat":406,"lon":405},{"facility":415,"status":110,"city":416,"state":29,"zip":417,"country":401,"countryCode":402,"cosmosGeoPoint":418,"geoPoint":422,"contacts":29},"Hospital Universitario Ramon y Cajal","Madrid","28034",{"type":116,"coordinates":419},[420,421],-3.70256,40.4165,{"lat":421,"lon":420},{"facility":424,"status":110,"city":425,"state":426,"zip":427,"country":428,"countryCode":429,"cosmosGeoPoint":430,"geoPoint":434,"contacts":29},"Castle Hill Hospital","Cottingham","Yorkshire","HU165JQ","United Kingdom","UK",{"type":116,"coordinates":431},[432,433],-0.7554,52.50243,{"lat":433,"lon":432},{"facility":436,"status":110,"city":437,"state":29,"zip":438,"country":428,"countryCode":429,"cosmosGeoPoint":439,"geoPoint":443,"contacts":29},"Cardiff and Vale University Health Board","Cardiff","CF14 4XW",{"type":116,"coordinates":440},[441,442],-3.18,51.48,{"lat":442,"lon":441},{"facility":445,"status":110,"city":446,"state":29,"zip":447,"country":428,"countryCode":429,"cosmosGeoPoint":448,"geoPoint":452,"contacts":29},"Barts Health NHS Trust","London","E12AT",{"type":116,"coordinates":449},[450,451],-0.12574,51.50853,{"lat":451,"lon":450},{"facility":454,"status":110,"city":446,"state":29,"zip":455,"country":428,"countryCode":429,"cosmosGeoPoint":456,"geoPoint":458,"contacts":29},"King's College Hospital NHS Foundation Trust","SE5 9RS",{"type":116,"coordinates":457},[450,451],{"lat":451,"lon":450},{"facility":460,"status":110,"city":446,"state":29,"zip":461,"country":428,"countryCode":429,"cosmosGeoPoint":462,"geoPoint":464,"contacts":29},"Chelsea and Westminster Hospital","SW109NH",{"type":116,"coordinates":463},[450,451],{"lat":451,"lon":450},{"facility":466,"status":110,"city":467,"state":29,"zip":468,"country":428,"countryCode":429,"cosmosGeoPoint":469,"geoPoint":473,"contacts":29},"Manchester University Nhs Foundation Trust","Manchester","M13 9WL",{"type":116,"coordinates":470},[471,472],-2.23743,53.48095,{"lat":472,"lon":471},{"type":475,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR","100627915","phase-2-study-to-evaluate-switching-to-brelovitug-for-the-treatment-of-chd-in-participants-receiving-bulevirtide-100627915",false,"NCT07454837","Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide","A Phase 2b\u002F3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)","Inclusion Criteria:\n\n1. Willing and able to provide written informed consent.\n2. Male or female, ≥18 years of age at Screening.\n3. Taking or willing to take TDF, TAF, or ETV at baseline, and willing to remain on stable treatment for the duration of the study.\n4. Currently taking bulevirtide treatment for CHD for ≥6 months at the time of Screening.\n5. HDV RNA ≥100 IU\u002FmL at Screening.\n\nExclusion Criteria:\n\n1. Evidence of decompensated liver disease (e.g., CTP Class B or C, history of hepatic encephalopathy, clinically significant ascites, or variceal bleeding).\n2. Known history of immune-complex disease.\n3. Active or clinically significant co-infection with hepatitis C virus (HCV) or human immunodeficiency virus (HIV).\n4. Evidence of other significant liver diseases (e.g., autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis).\n5. History of hepatocellular carcinoma (HCC) or evidence of HCC on screening imaging.","ALL","18 Years",{"count":486,"type":487},120,"ESTIMATED","INTERVENTIONAL",[490,491],"PHASE2","PHASE3","This is a Phase 2b\u002F3, randomized, open-label, multicenter trial evaluating the efficacy and safety of switching from bulevirtide to brelovitug for the treatment of chronic hepatitis Delta infection (CHD).",[494],"Chronic Hepatitis D","2026-08-21",{"date":497,"type":498},"2026-08-25","ACTUAL",{"date":500,"type":498},"2026-02-26",{"date":502,"type":487},"2029-03-30",{"name":5,"class":6},41]